NO985721D0 - Polymorfer av donepezilhydroklorid og fremstillingsprosess - Google Patents

Polymorfer av donepezilhydroklorid og fremstillingsprosess

Info

Publication number
NO985721D0
NO985721D0 NO985721A NO985721A NO985721D0 NO 985721 D0 NO985721 D0 NO 985721D0 NO 985721 A NO985721 A NO 985721A NO 985721 A NO985721 A NO 985721A NO 985721 D0 NO985721 D0 NO 985721D0
Authority
NO
Norway
Prior art keywords
polymorphs
manufacturing process
donepezil hydrochloride
donepezil
hydrochloride
Prior art date
Application number
NO985721A
Other languages
English (en)
Other versions
NO985721L (no
NO321267B1 (no
Inventor
Akio Imai
Hideaki Watanabe
Takashi Kajima
Yasushi Ishihama
Akiyo Ohtsuka
Tomohide Tanaka
Yukio Narabu
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1996/003881 external-priority patent/WO1997046526A1/en
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO985721D0 publication Critical patent/NO985721D0/no
Publication of NO985721L publication Critical patent/NO985721L/no
Publication of NO321267B1 publication Critical patent/NO321267B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
NO19985721A 1996-06-07 1998-12-07 Polymorfe av donepezilhydroklorid, fremgangsmater for fremstilling derav, anvendelse derav samt terapeutisk preparat inneholdende den samme. NO321267B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP14629396 1996-06-07
PCT/JP1996/003881 WO1997046526A1 (en) 1996-06-07 1996-12-27 Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production
US08/774,802 US6140321A (en) 1996-06-07 1996-12-30 Polymorphs of donepezil hydrochloride and process for production
PCT/JP1997/001932 WO1997046527A1 (en) 1996-06-07 1997-06-06 Polymorphs of donepezil hydrochloride and process for production

Publications (3)

Publication Number Publication Date
NO985721D0 true NO985721D0 (no) 1998-12-07
NO985721L NO985721L (no) 1999-01-28
NO321267B1 NO321267B1 (no) 2006-04-10

Family

ID=27307991

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985721A NO321267B1 (no) 1996-06-07 1998-12-07 Polymorfe av donepezilhydroklorid, fremgangsmater for fremstilling derav, anvendelse derav samt terapeutisk preparat inneholdende den samme.

Country Status (12)

Country Link
EP (2) EP1019374B1 (no)
AU (1) AU731282B2 (no)
CA (1) CA2252806C (no)
DK (1) DK1019374T3 (no)
ES (1) ES2188946T3 (no)
HK (1) HK1020952A1 (no)
NO (1) NO321267B1 (no)
NZ (1) NZ333197A (no)
RU (1) RU2190603C2 (no)
SI (1) SI9720038B (no)
SK (1) SK285312B6 (no)
WO (1) WO1997046527A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2282654C (en) * 1997-03-03 2009-02-03 Eisai Co., Ltd. Use of cholinesterase inhibitors to treat attention deficit hyperactivity disorder
GB9716879D0 (en) * 1997-08-08 1997-10-15 Shire Int Licensing Bv Treatment of attention deficit disorders
ATE260896T1 (de) 1997-12-05 2004-03-15 Eisai Co Ltd Donepezil polykristalle und verfharen zu ihrer herstellung
US6193993B1 (en) 1998-03-03 2001-02-27 Eisai Co., Ltd. Suppository containing an antidementia medicament
SK18812000A3 (sk) * 1998-06-16 2002-01-07 Eli Lilly And Company Spôsoby zvyšovania hladín acetylcholínu
US6288108B1 (en) 1998-06-16 2001-09-11 Eli Lilly And Company Methods for increasing levels of acetylcholine
CN1305377A (zh) * 1998-06-16 2001-07-25 伊莱利利公司 提高乙酰胆碱水平的方法
JP2003525903A (ja) 2000-03-03 2003-09-02 エーザイ株式会社 コリンエステラーゼ阻害剤の新規使用法
SI21223A (sl) * 2002-06-19 2003-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom
IL150509A (en) 2002-07-01 2007-07-04 Joseph Kaspi Pharmaceutical preparations containing donafazil hydrochloride
WO2004041281A1 (en) * 2002-11-01 2004-05-21 Oregon Health And Science University Treatment of hyperkinetic movement disorder with donepezil
WO2006011154A1 (en) * 2004-07-28 2006-02-02 Usv Limited A novel polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride (donepezil hydrochloride) and a process for producing thereof
US7186842B2 (en) 2003-02-12 2007-03-06 Usv, Ltd. Polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-y1] methyl piperidine hydrochloride (Donepezil hydrochloride) and a process for producing thereof
US20050288330A1 (en) * 2004-06-29 2005-12-29 Avinash Naidu Process for producing a polymorphic form of (1-Benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride (donepezil hydrochloride)
AU2003245029A1 (en) * 2003-04-16 2004-11-04 Hetero Drugs Limited Novel crystalline forms of donepezil hydrochloride
WO2006015338A2 (en) * 2004-07-30 2006-02-09 Dr. Reddy's Laboratories Ltd. Crystalline form of donepezil hydrochloride
DK1811957T3 (da) * 2004-10-19 2009-03-30 Krka Tovarna Zdravil D D Novo Fast farmaceutisk sammensætning omfattende donepezilhydrochlorid
WO2006090263A1 (en) * 2005-02-28 2006-08-31 Ranbaxy Laboratories Limited Stable form i donepezil hydrochloride and process for its preparation and use in pharmaceutical compositions
WO2006097341A1 (en) * 2005-03-17 2006-09-21 Synthon B.V. Process for making crystalline donepezil hydrochloride monohydrate
WO2006111983A2 (en) * 2005-04-21 2006-10-26 Jubilant Organosys Limited NOVEL POLYMORPHIC FORM OF (l-BENZYL-4-[(5,6-DIMETHOXY-l- INDANONE)-2-YL]METHYL PIPERIDINE HYDROCHLORIDE AND PROCESS FOR PREPARING THE SAME
GB0515803D0 (en) * 2005-07-30 2005-09-07 Pliva Hrvatska D O O Intermediate compounds
HU227474B1 (en) * 2005-12-20 2011-07-28 Richter Gedeon Nyrt Process for industrial scale production of high purity donepezil hydrochloride polymorph i.
EP2436381A1 (en) 2006-06-27 2012-04-04 Sandoz AG Crystallization of hydrohalides of pharmaceutical compounds
BRPI0720211A2 (pt) 2006-12-11 2013-12-24 Reviva Pharmaceuticals Inc Derivado de indanona, composição, e, uso de uma composição
DE102007037932A1 (de) 2007-08-11 2009-02-12 Alfred E. Tiefenbacher Gmbh & Co.Kg Donepezilhydrochlorid in amorpher Form enthaltende Tablette
WO2009049479A1 (fr) * 2007-09-28 2009-04-23 Tianjin Hemay Bio-Tech Co., Ltd. Polymorphes de sels de donepezil, leurs procédés de préparation et leurs utilisations
JP5562337B2 (ja) * 2008-12-17 2014-07-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 ドネペジルの多形結晶及びその製造方法
DE102010010998A1 (de) 2010-03-10 2011-09-15 Stada Arzneimittel Ag Feste pharmazeutische Zusammensetzung, umfassend Donepezil-Hydrochlorid der kristallinen polymorphen Form I
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
EP2502620A1 (en) 2011-03-24 2012-09-26 Krka Tovarna Zdravil, D.D., Novo Mesto Solid pharmaceutical composition comprising donepezil
CN110393440B (zh) * 2019-06-28 2021-08-13 顾美红 一种即热式烧水机

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi

Also Published As

Publication number Publication date
WO1997046527A1 (en) 1997-12-11
CA2252806A1 (en) 1997-12-11
ES2188946T3 (es) 2003-07-01
HK1020952A1 (en) 2000-05-26
DK1019374T3 (da) 2003-04-07
CA2252806C (en) 2005-11-22
SK167698A3 (en) 1999-06-11
AU2979297A (en) 1998-01-05
RU2190603C2 (ru) 2002-10-10
EP1019374A1 (en) 2000-07-19
SK285312B6 (sk) 2006-10-05
EP1211243A1 (en) 2002-06-05
NO985721L (no) 1999-01-28
NZ333197A (en) 2001-03-30
SI9720038A (sl) 1999-06-30
EP1019374B1 (en) 2003-01-02
EP1211243B1 (en) 2009-10-14
SI9720038B (sl) 2010-06-30
NO321267B1 (no) 2006-04-10
AU731282B2 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
NO985721L (no) Polymorfer av donepezilhydroklorid og fremstillingsprosess
NO993676D0 (no) Fremgangsmåte for fremstilling og rensing av et N-alkylert aspartamderivat
DK1041879T4 (da) Desinfektionsmiddel og fremstillingsmetode
IS4940A (is) Erýtrómýsín og aðferð við að framleiða þau
DE69607164D1 (de) Schalldämpfungsverfahren und schalldämmelement dafür
NO984161D0 (no) Fremgangsmåte og innretning for fremstilling av etalisk jern
DK0832565T3 (da) Mælkeerstatningsprodukt og fremgangsmåde til fremstilling deraf
DE69616057T2 (de) Umhülltes retroreflektierendes element und herstellungsverfahren
NO20000695D0 (no) Fiberstruktur og fremgangsmÕte for fremstilling derav
NO974500L (no) Blandinger og fremgangsmåter for inhibering av trombogenese
NO991382L (no) Mellomprodukter og fremgangsmÕte for fremstilling av olanzapin
NO951369L (no) Rörenhet og fremgangsmåte ved fremstilling av denne
NO20012963L (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
IS3792A7 (is) Benzodiazepinones og aðferð til framleiðslu þess
ATE216063T1 (de) Halbleiterbrückenzünder und herstellungsverfahren dafür
EE03351B1 (et) Meetod lerkanidipiinhüdrokloriidi valmistamiseks
DE69621875T2 (de) Polarisationsunabhängiger Demultiplexer und Herstellungsverfahren
DK0866658T3 (da) Mejeriprodukt og fremgangsmåde til fremstilling deraf
NO963393D0 (no) Börste og fremgangsmåte ved dens fremstilling
NO994505L (no) Forbedret fremgangsmåte for fremstilling av tiazolidindioner og nye tiazolidindioner
DK0891938T3 (da) Maskine og fremgangsmåde til stabling
DE69730605D1 (de) Dragier-produkte und herstellungsverfahren
NO974826D0 (no) Fremgangsmåte for fremstilling av racemisk og enantiomert 1-(pyridyl)-2-cykloheksyletylamin
NO20001827D0 (no) Stator og fremgangsmåte for fremstilling av en stator
NO20012099L (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- karbinoler og beslektede forbindelser

Legal Events

Date Code Title Description
MK1K Patent expired